Abstract
Chronic lymphocytic leukemia of CD5+ B cells is clinically a heterogeneous disease [1]. This heterogeneity is also easily demonstrable in vitro [2]. In the vast majority of the cases B-CLL is a malignancy of CD5+ B cells with a very low capacity for proliferation in peripheral blood and with a phenotype resembling that of virgin [2] and mantle zone memory [3] B cells. In some cases the stage of differentiation is more advanced, as reflected by the capacity of the leukemic cells to secrete immunoglobulin [Ig]. In other rare cases Ig production may be very low and undetectable by immunofluorescence. The possibility that B-CLL might be a disease of differentiating leukemic B cells has not been extensively studied, but our own unpublished observations suggest that the stage of differentiation of the B-CLL cells may be different in peripheral lymphoid organs and in the bone marrow of the patient than in the peripheral blood, and the capacity for proliferation seems often to be about a 10-fold higher in these tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Freedman AS (1990) Immunobiology of chronic lymphocytic leukemia. Hematol Oncol Clin North Am 4:405–430.
Nilsson K (1992) The control of growth and differentiation in chronic lymphocytic leukemia (B-CLL) cells. In: Cheson BD (ed) Chronic lymphocytic leukemia. Marcel Dekker, New York, pp 33–61.
Schena M, Larsson L-G, Gottardi D Gaidano G, Carlsson M, Nilsson K, caligaris-Cappio (1992) Growth and differentiation-associated expression of BCL-2 in B-chronic lymphocytic leukemia ells. Blood, in press.
Fu SM, Winchester, RJ, Feizi T, Walzer D, Kunkel HG (1974) Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone marrow-derived lymphocytes. Proc Natll Acad Sci. USA 71:4487–4490.
Tötterman TH, Nilsson K, Sundström C (1980) Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature 288:176–178.
Aguilar-Santelises M, Magnusson R, Svenson SB, Loftenius A, Andersson B, Mellstedt H, Jondal M (1991) Expression of interleukin-1α, interleukin-1β and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression. Clin exp Immunol 84:422–428.
Cordingley FT, Hoffbrand AV, Heslop HE, Turner M, Bianchi A, Reittie JE, Vykarnam A, Brenner MK (1988). Tumor necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 969-971.
Foa R, Massaia M, Cardona S, Tos G, Bianchi A, Attisano C, Guarini A, Di Celle PF, Fierro MT (1990) Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease. Blood 76:393–400.
Schena M, Gaidano G, Gottardi D, Malavasi F, Larsson L-G, Nilsson K, Caligaris-Cappio F (1992) Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. Leukemia 6:120–125.
Biondi, A. Rossi V, Bassan, R. Barbui, T. Bettoni, S. Siroo, M. Mantovani, A. Rambaldi A (1989) Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73:1279–1284.
Safarti M, Fournier S, Christoffersen M, Biron G (1990) Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk Res 14:47–55.
Foa R, Massaia M, Cardona S, Tos G, Bianchi A, Attisano C, Guarini A, di Celle PF, Fierro MT (1990) Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease. Blood 76:393–400.
Hahn T, Kusminsky G, Bassous L, Berrebi A (1991) Tumor necrosis factor production in B cell chronic lymphocytic leukemia. Leuk Lymphoma 4:117–121.
Lahat N, Aghai E, Maroun B, Kinarty A, Quitt M, Froom P (1991) Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukaemia (B-CLL) and autoimmunity. Clin exp Immunol 85:302–306.
Lantz O, Grillot-Courvalin C, Schmitt C, Fermand JP, Brouet J-C (1985) Interleukin-2 induced proliferation of leukemic B cells. J. Exp. Med. 161: 1225–1230.
Carlsson M, Tötterman TH, Matsson P, Nilsson K (1988) Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiation by TPA. Blood 71:415–421.
Digel W, Schöniger W, Stefanic M, Janssen H, Buck C, Schmid M, Raghavachar A, Porzsolt F (1990) Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood 76:1607–1613.
Heilig B, Mapara M, Brockhaus M, Krauth K, Dörken B (1991) Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin Immunol Immunopathol 61:260–267.
Hirata Y, Taga T, Hibi M, Nakano N, Hirano T, Kishimoto T (1989) Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J Immunol 143:2900–2906.
Brown RD, Gorenc B, Gibson J, Warburton P, Joshua D (1992) Interleukin 4 and 6 receptor expression on B cell lines and the lymphocytes of patients with B cell malignancies. Leuk Lymphoma 6: 377–383.
Larsson L-G, Schena M, Carlsson M, Sällström J, Nilsson K (1991) Expression of the c-myc protein is downregulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells. Blood 77:1025–1032.
Larsson L-G, Carlsson M, Schena M, Lantz M, Caligaris-Cappio F, Nilsson K (1992) Interleukin-2 enhances the production of tumor necrosis factor-a in activated B-type chronic lymphocytic leukemia (B-CLL) cells. Leukemia in press.
Jernberg-Wiklund H, Pettersson M, Carlsson M, Nilsson K (1992) Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell lie, U-266, during long term in vitro culture and the development of a possible autocrine IL-6 loop. Leukemia 6:310–318.
Sung S-SJ, Jung LKL, Walters JA, Chen W, Wang CY, Fu SM (1988) Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med 168:1539–1551.
Kehrl JH, Miller A, Fauci AS (1987) Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med 166:786–791.
Rieckmann P, D Alessandro, Nordan RP, Fauci S, Kehrl JH (1991) IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. J Immunol 146:3462–3468.
Digel W, Stefanic M, Schöniger W, Buck C, Raghavachar A, Frickhofen N, Porzsolt F (1989) Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 73:1242–1246.
Digel W, Schöniger W, Stefanie M, Janssen H, Buck C, Schmid M, Raghavachar A, Porzsolt F (1990) Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood 76:1607–1613.
Heilig M, Mapara M, Brockhaus M, Krauth K, Dörken B (1991) Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin Immunol Immunopathol 61:260–267.
Lindemann A, Ludwig W-D, Oster W, Mertelsmann R, Herrmann F (1989) High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 73:880–884.
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci. USA 82:5490–5494.
Splawski B, McAnally LM, Lipsky PE (1990) IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). J. Immunol 144:562–569.
Tosato G, Gerrard TL, Goldman NG, Pike S (1988) Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-β2/B cell stimulatory factor/IL-6. J Immunol 140:4329–4336.
Drexler HG, Brenner MK, Coustan-Smith E., Gignac M, Hoffbrand AV, (1988) Analysis of signal transduction in chronic lymphocytic leukemia cells. Blood 71:1461–1469.
Ghaderi AA, Richardson P, Cardona C, Millsum J, Ling N, Gillis S, Ledbetter J, Gordon J. (1988) Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents. Leukemia 2:165–170.
Defrance T, Fluckiger A-C, Rossi J-F, Rousset F, Bancgereau J (1991) In vitro activation of B-CLL cells. Leuk Lymphoma, Supplement, pp. 13-19.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nilsson, K. et al. (1992). On the Role of Endogenously Produced TNF-α and IL-6 as Regulators of Growth and Differentiation of B-Type Chronic Lymphocytic Leukemia Cells In Vitro. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1992. Current Topics in Microbiology and Immunology, vol 182. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77633-5_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-77633-5_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77635-9
Online ISBN: 978-3-642-77633-5
eBook Packages: Springer Book Archive